doi: 10.1093/jnci/95.7.500.
Better blocker: RNA interference dazzles research community
- PMID: 12671010
- DOI: 10.1093/jnci/95.7.500
Item in Clipboard
Better blocker: RNA interference dazzles research community
J Natl Cancer Inst.
.
No abstract available
Similar articles
-
Blocking cancer with RNA interference moves toward the clinic.J Natl Cancer Inst. 2005 May 4;97(9):626-8. doi: 10.1093/jnci/97.9.626. J Natl Cancer Inst. 2005. PMID: 15870429 No abstract available.
-
Oncogene suppression by small interfering RNAs.Curr Pharm Biotechnol. 2004 Aug;5(4):349-54. doi: 10.2174/1389201043376733. Curr Pharm Biotechnol. 2004. PMID: 15320765 Review.
-
Atelocollagen-mediated siRNA delivery: future promise for therapeutic application.Ther Deliv. 2014 Apr;5(4):369-71. doi: 10.4155/tde.14.8. Ther Deliv. 2014. PMID: 24856162 No abstract available.
-
[RNA interference: biogenesis molecular mechanisms and its applications in cervical cancer].Rev Invest Clin. 2010 Jan-Feb;62(1):63-80. Rev Invest Clin. 2010. PMID: 20415061 Review. Spanish.
-
RNA interference advances to early-stage clinical trials.J Natl Cancer Inst. 2010 Oct 6;102(19):1459-61. doi: 10.1093/jnci/djq405. Epub 2010 Sep 24. J Natl Cancer Inst. 2010. PMID: 20870977 No abstract available.
Cited by
-
Silencing Fas-associated phosphatase 1 expression enhances efficiency of chemotherapy for colon carcinoma with oxaliplatin.World J Gastroenterol. 2010 Jan 7;16(1):112-8. doi: 10.3748/wjg.v16.i1.112. World J Gastroenterol. 2010. PMID: 20039457 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
